Literature DB >> 15474453

Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells.

Winston S N Shim1, Shujia Jiang, Philip Wong, Jack Tan, Yeow Leng Chua, Yong Seng Tan, Yoong Kong Sin, Chong Hee Lim, Terrance Chua, Ming Teh, Te Chih Liu, Eugene Sim.   

Abstract

Bone marrow mesenchymal stem cells have been shown to transdifferentiate into cardiomyocytes after 5-azacytidine treatment or co-culturing with rodent cardiomyocytes. We investigate if adult human bone marrow stem cells can be differentiated ex vivo into cardiomyocyte-like cells (CLCs) independent of cytotoxic agents or co-culturing technique. Sternal bone marrow was collected from 16 patients undergoing coronary artery bypass surgery. Mesenchymal stem cells were differentiated in a cardiomyogenic differentiation medium containing insulin, dexamethasone, and ascorbic acid. Differentiation towards CLCs was determined by induced expression of cardiomyocyte-specific proteins. Differentiated CLCs expressed multiple structural and contractile proteins that are associated with cardiomyocytes. Thin filament associated myofibrillar proteins were detected early in the cells, with cardiac troponin I, sarcomeric tropomyosin, and cardiac titin among the first expressed. Some CLCs were found to develop into a nascent cardiomyocyte phenotype with cross-striated myofibrils characterized by alpha-actinin-positive Z bands after 4-5 passages in differentiated culture. These lineage-defined CLCs may be potentially useful for repairing damaged myocardium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15474453     DOI: 10.1016/j.bbrc.2004.09.087

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  53 in total

1.  The combination of angiotensin II and 5-azacytidine promotes cardiomyocyte differentiation of rat bone marrow mesenchymal stem cells.

Authors:  YuJie Xing; AnLin Lv; Li Wang; XueBo Yan
Journal:  Mol Cell Biochem       Date:  2011-09-21       Impact factor: 3.396

Review 2.  Getting to the heart of tissue engineering.

Authors:  Luda Khait; Louise Hecker; Nicole R Blan; Garrett Coyan; Francesco Migneco; Yen-Chih Huang; Ravi K Birla
Journal:  J Cardiovasc Transl Res       Date:  2008-01-29       Impact factor: 4.132

3.  Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells.

Authors:  Simi M Chacko; Shabnam Ahmed; Karuppaiyah Selvendiran; M Lakshmi Kuppusamy; Mahmood Khan; Periannan Kuppusamy
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-22       Impact factor: 4.249

4.  Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential.

Authors:  Georg Siegel; Petra Krause; Stefanie Wöhrle; Patrick Nowak; Miriam Ayturan; Torsten Kluba; Bernhard R Brehm; Birgid Neumeister; David Köhler; Peter Rosenberger; Lothar Just; Hinnak Northoff; Richard Schäfer
Journal:  Stem Cells Dev       Date:  2012-03-13       Impact factor: 3.272

Review 5.  Mesenchymal stem cells for the treatment of heart failure.

Authors:  Shunsuke Ohnishi; Hajime Ohgushi; Soichiro Kitamura; Noritoshi Nagaya
Journal:  Int J Hematol       Date:  2007-07       Impact factor: 2.490

Review 6.  Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases.

Authors:  Jakob Reiser; Xian-Yang Zhang; Charles S Hemenway; Debasis Mondal; Leena Pradhan; Vincent F La Russa
Journal:  Expert Opin Biol Ther       Date:  2005-12       Impact factor: 4.388

7.  Hearty slices to plan for future health.

Authors:  Brenda Russell; John M Collins
Journal:  Cardiovasc Res       Date:  2008-12-15       Impact factor: 10.787

8.  Mesenchymal progenitor cells derived from traumatized human muscle.

Authors:  W M Jackson; A B Aragon; F Djouad; Y Song; S M Koehler; L J Nesti; R S Tuan
Journal:  J Tissue Eng Regen Med       Date:  2009-02       Impact factor: 3.963

9.  Donor mesenchymal stromal cells (MSCs) undergo variable cardiac reprogramming in vivo and predominantly co-express cardiac and stromal determinants after experimental acute myocardial infarction.

Authors:  Gustavo Yannarelli; James N Tsoporis; Jean-Francois Desjardins; Xing Hua Wang; Ali Pourdjabbar; Sowmya Viswanathan; Thomas G Parker; Armand Keating
Journal:  Stem Cell Rev Rep       Date:  2014-04       Impact factor: 5.739

10.  Human cardiac progenitor cells engineered with Pim-I kinase enhance myocardial repair.

Authors:  Sadia Mohsin; Mohsin Khan; Haruhiro Toko; Brandi Bailey; Christopher T Cottage; Kathleen Wallach; Divya Nag; Andrew Lee; Sailay Siddiqi; Feng Lan; Kimberlee M Fischer; Natalie Gude; Pearl Quijada; Daniele Avitabile; Silvia Truffa; Brett Collins; Walter Dembitsky; Joseph C Wu; Mark A Sussman
Journal:  J Am Coll Cardiol       Date:  2012-07-26       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.